Bone organ as well as construction method and application thereof

By combining dynamic tensile stress and the use of macrophages in bone organoid construction, the mechanical environment of natural bone is simulated, and the problem of poor bone repair results caused by the time-consuming construction of bone organoids and the composition of single cells in the prior art is solved. , realizes the rapid construction of bone organoids with excellent bone repair effects.

CN119060939AActive Publication Date: 2024-12-03PEKING UNIV SCHOOL OF STOMATOLOGY

Patent Information

Application Number
CN202411197540.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-12-03
Estimated Expiration
2044-08-29

AI Technical Summary

Technical Problem

The existing bone organoid construction methods take a long time, lack control over cell fate, and the composition of a single cell leads to poor bone repair results, lack of dynamic mechanical microenvironment and immune cell participation in simulated bone tissue formation.

Method used

Three-dimensional culture technology is used to combine dynamic tensile stress, a mixture of stem cells and macrophages is used, and cured through hydrogel matrix material to form bone organoids with immune regulation functions, simulate the mechanical environment of natural bones and regulate cell fate.

Benefits of technology

It significantly shortens the construction time of bone organoids, improves bone repair effect, and forms bone organoids with mature functions. It can achieve a repair effect comparable to autologous bones 14 days after implantation, and promotes osteogenic differentiation of mesenchymal stem cells. and inhibit bone loss.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060939A_ABST
    Figure CN119060939A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biomedical engineering, and relates to a bone organ as well as a construction method and application thereof. The bone organ is obtained by performing three-dimensional culture on a cell mixture, and the cell mixture comprises stem cells and macrophages. According to the bone-like organ and the construction method thereof, the bone-like organ can be rapidly prepared, the prepared bone-like organ is small in difference from natural bones, cell fate can be regulated and controlled, and osteogenesis and bone repair can be better promoted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomedical engineering and relates to a bone organoid and a construction method and use thereof. Background Art

[0002] Bone defects in the oral, craniomaxillofacial and other parts of the body have various causes, high incidence, complex morphology, and difficulty in bone regeneration, which seriously affect the patient's appearance, chewing, pronunciation, and movement functions, causing serious damage to the patient's quality of life and physical and mental health. At present, small-scale bone defects can be repaired by filling with materials such as artificial bone powder. For larger bone defects, current treatment methods include autologous bone transplantation, allogeneic transplantation, and synthetic bone substitutes, but these methods have limitations. Autologous bone transplantation causes damage to the donor site and causes great trauma; allogeneic transplantation and synthetic bone substitutes have problems such as immunogenicity, infection, poor integration, and insufficient vascularization.

[0003] Organoids are simple in vitro models of tissue engineering based on cells. They are three-dimensional cultures with biomimetic spatial characteristics formed by cells through self-renewal and self-organization or under the induction of biomaterials. They can simulate or partially simulate the cell types, structures and functions of tissues and organs in the body. Currently, organoids play a vital role in the study of tissue development, disease occurrence and development mechanisms, drug screening and tissue engineering. Therefore, engineered tissues constructed based on bone organoids can provide a new way for bone tissue regeneration and repair, and can also be used as a model for studying bone tissue development and drug screening.

[0004] However, in bone organoid technology, although researchers have made many efforts to construct and apply bone organoids, the construction of bone organoids takes a long time, and there are still limitations such as lack of regulation of cell fate, poor osteogenesis, single cell composition, and obvious differences from natural bones. For example, the patent application "A 3D bioprinted bone tissue engineering scaffold based on bone organoids" (application number: CN202210911808.X) constructs a bone organoid including a shell, an outer bionic periosteum, and an internal microsphere filling, simulating the macroscopic structure of bone tissue in a static environment, but does not simulate the dynamic mechanical microenvironment that is indispensable in the process of bone tissue formation, and lacks regulation of cell fate. Another example is the patent application "A system for constructing bone organoids and its use method" (application number: CN202311219797.X) selects at least one cell or multiple cells including bone marrow stromal cells, osteoprogenitor cells, preosteoblasts, osteoblasts, bone lining cells, osteocytes or osteoclasts for the construction of bone organoids. For example, the paper “Developmentally Engineered Callus Organoid Bioassemblies Exhibit Predictive In Vivo Long Bone Healing” (DOI number: 10.1002 / advs.201902295; PMID number: 31993293) chose to construct bone organoids with stem cells from a single periosteum. However, these cells are mostly osteoblasts and lack immune cells such as macrophages that play a key role in bone immune homeostasis and bone repair and regeneration. Summary of the invention

[0005] The primary purpose of the present invention is to provide a bone organoid that can be quickly constructed, has little difference from natural bone, can regulate cell fate, and can better promote bone formation and bone repair.

[0006] To achieve this object, in a basic embodiment, the present invention provides a bone organoid, wherein the bone organoid is obtained by three-dimensionally culturing a cell mixture, wherein the cell mixture comprises stem cells and macrophages.

[0007] In a preferred embodiment, the present invention provides a bone organoid, wherein the stem cells are selected from one or more of umbilical cord blood mesenchymal stem cells, bone marrow mesenchymal stem cells, adipose mesenchymal stem cells, and induced pluripotent stem cells.

[0008] In a preferred embodiment, the present invention provides a bone organoid, wherein the macrophages are bone marrow-derived macrophages and / or peripheral blood-derived macrophages.

[0009] In a preferred embodiment, the present invention provides a bone organoid, wherein the number ratio of the stem cells to the macrophages is (2-3):1.

[0010] In a preferred embodiment, the present invention provides a bone organoid, wherein the cell mixture further comprises a hydrogel matrix material.

[0011] In a preferred embodiment, the present invention provides a bone organoid, wherein the hydrogel matrix material is selected from one or more of methacrylated gelatin, hyaluronic acid, sodium alginate, silk fibroin, carboxymethyl chitosan, chondroitin sulfate, and collagen.

[0012] In a preferred embodiment, the present invention provides a bone organoid, wherein the density of all cells formed in the hydrogel matrix material is (1-5)×10 6 Pieces / mL.

[0013] The second object of the present invention is to provide a method for constructing a bone organoid as described above, so as to be able to quickly prepare the bone organoid as described above, so that the prepared bone organoid has little difference from natural bone, can regulate cell fate, and can better promote bone formation and bone repair.

[0014] To achieve this object, in a basic embodiment, the present invention provides a method for constructing a bone organoid as described above, the method comprising the following steps:

[0015] (1) uniformly mixing the materials in the cell mixture in a three-dimensional culture reactor;

[0016] (2) solidifying the hydrogel matrix material;

[0017] (3) Performing cell culture to obtain the bone organoid.

[0018] In a preferred embodiment, the present invention provides a method for constructing bone organoids as described above, wherein in step (1), the three-dimensional culture reactor is a three-dimensional culture reactor based on dynamic tensile stress.

[0019] The so-called three-dimensional culture is a technology for cells to grow, proliferate and migrate in three-dimensional space. The cells are encapsulated in a matrix with a three-dimensional structure or on a synthetic scaffold material. Compared with traditional two-dimensional cell culture, three-dimensional cell culture is closer to the growth state of cells in the physiological environment in the body, including cell-to-cell interactions, signal transduction, and the response of the extracellular matrix. Therefore, three-dimensional culture can better simulate the biological characteristics of tissues and organs, providing more possibilities for biomedical research, drug development, and tissue engineering. For a detailed introduction to three-dimensional culture, please refer to the literature: Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment (DOI number: 10.1021 / acs.chemrev.7b00094).

[0020] Dynamic tensile stress three-dimensional culture is different from the previous three-dimensional culture in a static environment. It is a three-dimensional culture method based on a dynamic environment. It combines the entire three-dimensional culture system with the chamber and uses dynamic tensile stress equipment (such as CELL TANK equipment) to dynamically stretch the chamber, thereby driving the dynamic stretching of the entire three-dimensional culture system, so that dynamic tensile stress is generated while the stretching deformation occurs. Therefore, the cells in culture are also in a dynamic tensile stress environment.

[0021] In a preferred embodiment, the present invention provides a method for constructing bone organoids as described above, wherein the three-dimensional culture reactor based on dynamic tensile stress is subjected to plasma spraying treatment to remove impurities on the inner surface, and the inner surface is coated with polylysine to improve the hydrophilicity and adhesion of the inner surface before adding the cell mixture.

[0022] In a preferred embodiment, the present invention provides a method for constructing a bone organoid as described above, wherein in step (2), the curing is photocuring, the wavelength of the photocuring is 400-420 nm, and the time of the photocuring is 30-60 s.

[0023] In a preferred embodiment, the present invention provides a method for constructing bone organoids as described above, wherein in step (3), during cell culture, the frequency of dynamic tensile stress is 0.5-0.8 Hz, the time is 2-3 h / day, and the ratio is 8-10%.

[0024] The third object of the present invention is to provide the use of the bone organoid as described above for preparing bone repair materials or in vitro research models, so as to better promote osteogenesis and bone repair.

[0025] To achieve this object, in a basic embodiment, the present invention provides the use of the bone organoid as described above for preparing a bone repair material or an in vitro research model.

[0026] In a preferred embodiment, the present invention provides the use of the bone organoids as described above for preparing bone repair materials or in vitro research models, wherein the bone repair materials are used to treat bone defects or osteoporosis, and the in vitro research models are used for tissue development research or drug screening research.

[0027] The beneficial effect of the present invention is that by utilizing the bone organoids and the construction method thereof of the present invention, bone organoids can be rapidly prepared, the prepared bone organoids have little difference from natural bones, cell fate can be regulated, and bone formation and bone repair can be better promoted.

[0028] Currently, bone organoids are mostly constructed using single osteoblasts without considering the bone immune microenvironment, which is significantly different from natural bone tissue. The present invention introduces immune cells such as macrophages to regulate the bone immune microenvironment on the basis of osteoblasts, thereby forming functional bone organoids with immunomodulatory effects.

[0029] Currently, the construction of bone organoids is time-consuming, lacks regulation of cell fate, and has poor osteogenesis effect. The present invention simulates the mechanical environment of natural bone tissue, constructs a dynamic tensile stress three-dimensional culture system, and mechanically regulates cell fate. At the same time, it can shorten the time for constructing bone organoids. Obtaining bone organoids can improve the osteogenesis effect and promote the formation of mature functional bone organoids.

[0030] The bone organoids provided by the present invention have significantly improved abilities of promoting osteogenic differentiation of mesenchymal stem cells and inhibiting bone loss compared with mesenchymal stem cell apoptosis vesicles alone, and have broad clinical application prospects in the treatment of senile osteoporosis.

[0031] Compared with the bone organoids constructed based on static culture and single cell in previous studies, the bone organoids constructed by the present invention have a more excellent bone repair effect. Currently, autologous bone transplantation is the gold standard for treating bone defects, but autologous bone transplantation can cause damage to the donor area. The bone organoids constructed by the present invention can achieve bone regeneration and repair effects comparable to autologous bone repair 14 days after implantation. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 The figure is a flowchart of an exemplary method for constructing bone organoids according to the present invention.

[0033] Figure 2 The results of alkaline phosphatase (ALP) detection of bone organoids constructed in Examples 1-3 and Comparative Examples 1-8 are shown, wherein: (a) ALP staining, scale bar: 1 cm; (b) ALP activity quantification.

[0034] Figure 3 The results of immune polarization detection of bone organoids constructed in Comparative Example 6 and Example 1 are shown, including: (a) expression of immune polarization-related genes (**P<0.01, ***P<0.001); (b) immunofluorescence staining of immune polarization-related protein iNOS; (c) immunofluorescence staining of immune polarization-related protein ARG-1.

[0035] Figure 4 The results of femoral defect repair test 14 days after implantation of bone organoids constructed in Example 1, Comparative Example 1, Comparative Example 6, and Comparative Example 8, including: (a) Micro-CT scanning reconstruction and (b) quantitative analysis (ns no statistical difference, *P < 0.05, **P < 0.01, ***P < 0.001, scale bar: 1 mm). DETAILED DESCRIPTION

[0036] The specific implementation modes of the present invention are further described below through examples and drawings.

[0037] Example 1: Cultivation of bone organoids (I)

[0038] according to Figure 1 The process shown in the figure is used to culture bone organoids, which specifically includes the following steps:

[0039] (1) The inner surface of the dynamic tensile stress chamber (CELL TANK, 20×20 mm) was first treated with nitrogen plasma spraying (the plasma nozzle was 2 mm away from the inner surface and the moving speed was 2 mm / s) to remove impurities on the inner surface. Then, a layer of poly-lysine solution (0.1% (W / V)) was coated on the inner surface and incubated overnight in the dark. The poly-lysine solution was discarded the next day and dried at 60°C for 1 h for later use to improve the hydrophilicity and adhesion of the chamber surface.

[0040] (2) 10 wt% (5-15 wt%) methacryloyl gelatin (GelMA) was mixed with bone marrow mesenchymal stem cells (obtained by the adherence screening method: flush out the cells in the bone marrow cavity with complete culture medium (α-MEM medium + 10% (mass fraction) fetal bovine serum + 1% (mass fraction) penicillin-streptomycin) using a syringe, collect the bone marrow fluid and inoculate it into a culture dish, remove the suspended cells after 48 hours, and the adherent cells are bone marrow mesenchymal stem cells), bone marrow-derived macrophages (obtained by the adherence screening + macrophage colony stimulating factor induction method) The cells in the bone marrow cavity were flushed out with complete culture medium (α-MEM medium + 10% (mass fraction) fetal bovine serum + 1% (mass fraction) penicillin-streptomycin) using a syringe, and the bone marrow fluid was collected and inoculated into a culture dish. After 48 hours, the suspended cells were collected and re-inoculated into the culture dish, and macrophage colony stimulating factor was added at a working concentration of 40 ng / ml. After 72 hours of culture, the adherent cells were bone marrow-derived macrophages) and mixed, wherein the ratio of bone marrow mesenchymal stem cells to bone marrow-derived macrophages was 2:1, and the final cell density was 3×10 6 The mixture was then injected into the dynamic tensile stress chamber, and after 405nm light curing for 60 seconds, the hydrogel was tightly adhered to the dynamic tensile stress chamber.

[0041] (3) The chamber was placed in a dynamic tensile stress device (CELL TANK, corresponding to 20×20 mm), and the ratio, frequency, and time of the dynamic tensile stress were set to 10%, 0.5 Hz, and 2 h / day, respectively, so that the dynamic tensile stress chamber was deformed and the three-dimensional culture system was driven to undergo dynamic tensile stress. Cell culture was started (cultured in a medium containing 5% (volume fraction) CO 2 +95% (volume fraction) air at 37°C constant temperature incubator; complete culture medium composition: α-MEM medium +10% (mass fraction) fetal bovine serum +1% (mass fraction) penicillin-streptomycin; culture medium was replaced every 2 days) and cultured for a total of 28 days.

[0042] Example 2: Cultivation of bone organoids (II)

[0043] The ratio of bone marrow mesenchymal stem cells to bone marrow-derived macrophages in step (2) was changed to 3:1.

[0044] The rest is the same as in Example 1.

[0045] Example 3: Cultivation of bone organoids (III)

[0046] The proportion, frequency and time of dynamic tensile stress in step (3) were changed to 8%, 0.8 Hz and 3 h / day respectively.

[0047] The rest is the same as in Example 1.

[0048] Comparative Example 1: Cultivation of Bone Organoids (IV)

[0049] In step (2), only the same amount of bone marrow mesenchymal stem cells were added without adding bone marrow-derived macrophages, and the final cell density changed accordingly.

[0050] The rest is the same as in Example 1.

[0051] Comparative Example 2: Cultivation of Bone Organoids (V)

[0052] The ratio of the number of bone marrow mesenchymal stem cells to bone marrow-derived macrophages in step (2) was changed to 1:1.

[0053] The rest is the same as in Example 1.

[0054] Comparative Example 3: Cultivation of Bone Organoids (VI)

[0055] The ratio of bone marrow mesenchymal stem cells to bone marrow-derived macrophages in step (2) was changed to 4:1.

[0056] The rest is the same as in Example 1.

[0057] Comparative Example 4: Cultivation of Bone Organoids (VII)

[0058] The proportion, frequency and time of dynamic tensile stress in step (3) were changed to 15%, 0.25 Hz and 1 h / day respectively.

[0059] The rest is the same as in Example 1.

[0060] Comparative Example 5: Cultivation of Bone Organoids (VIII)

[0061] The proportion, frequency and time of dynamic tensile stress in step (3) were changed to 5%, 1 Hz and 4 h / day respectively.

[0062] The rest is the same as in Example 1.

[0063] Comparative Example 6: Cultivation of Bone Organoids (IX)

[0064] In step (3), the proportion, frequency and time of the dynamic tensile stress are not set, that is, dynamic tensile stress three-dimensional culture is not performed, but static culture is performed.

[0065] The rest is the same as in Example 1.

[0066] Comparative Example 7: Cultivation of Bone Organoids (X)

[0067] The bone marrow-derived macrophages in step (2) are replaced with osteoclasts.

[0068] The rest is the same as in Example 1.

[0069] Comparative Example 8: Cultivation of Bone Organoids (XI)

[0070] In step (2), only the same amount of bone marrow mesenchymal stem cells were added without adding bone marrow-derived macrophages, and the final cell density changed accordingly.

[0071] In step (3), the proportion, frequency and time of the dynamic tensile stress are not set, that is, dynamic tensile stress three-dimensional culture is not performed, but static culture is performed.

[0072] The rest is the same as in Example 1.

[0073] Example 4: Identification of Bone Organoids

[0074] The bone organoids prepared in Examples 1-3 and Comparative Examples 1-7 were identified as follows.

[0075] ALP staining and ALP activity quantification were performed using an alkaline phosphatase (ALP) staining kit (Biyuntian, China) and an ALP quantification kit (Biyuntian, China). The results are shown in Figure 2 .Depend on Figure 2 The results show that the ALP staining of the bone organoids constructed in Examples 1-3 is darker than that in Comparative Examples 1-8, and ALP quantification also shows that the ALP activity of the bone organoids constructed in Examples 1-3 is higher than that in Comparative Examples 1-8, and the osteogenic differentiation is better.

[0076] This shows that compared with using bone marrow mesenchymal stem cells alone, adding bone marrow-derived macrophages can better construct bone organoids, better regulate cell fate, and better osteogenic differentiation; compared with bone marrow mesenchymal stem cells plus osteoclasts, bone marrow mesenchymal stem cells plus bone marrow-derived macrophages can better construct bone organoids, better regulate cell fate, and better osteogenic differentiation; compared with static culture, dynamic tensile stress culture can better construct bone organoids, better regulate cell fate, and better osteogenic differentiation; in dynamic tensile stress culture, the ratio of bone marrow mesenchymal stem cells to bone marrow-derived macrophages is 2-3:1, the frequency of dynamic tensile stress is 0.5-0.8Hz, the time is 2-3h / day, and the ratio is 8-10%, which is the optimal culture condition.

[0077] Real-time fluorescence quantitative PCR (qPCR) was used to detect the expression of macrophage polarization-related genes in bone organoids to observe whether dynamic tensile stress would regulate immune polarization in bone organoids. Figure 3 As shown, dynamic tensile stress culture reduced the expression of pro-inflammatory factors Tnf-α and Il-1β, and increased the expression of anti-inflammatory factors Tgf-β and Il-10.

[0078] By performing immunofluorescence staining on the marker proteins of macrophage immune polarization in bone organoids, we observed whether dynamic tensile stress would regulate the immune polarization in bone organoids. Figure 3 As shown, dynamic tensile stress culture reduced the expression of pro-inflammatory marker iNOS and increased the expression of anti-inflammatory marker ARG-1.

[0079] In summary, dynamic tensile stress culture and the addition of macrophages can regulate the immune microenvironment within bone organoids and promote the transformation of bone organoids to an anti-inflammatory immune microenvironment that is more conducive to bone tissue repair.

[0080] Example 5: Experiment on repairing femoral defects in mice with bone organoids

[0081] The bone organoids prepared in Examples 1-3, Comparative Example 1, Comparative Example 6, and Comparative Example 8 and autologous bones (taken from the contralateral tibia of the femoral defect side of the mouse) were tested for repairing the femoral defect of the mouse. The specific test method is as follows:

[0082] After 21 days of in vitro culture, bone organoids and autologous bone groups were implanted into femoral defects (1 mm diameter through defects) of mice (C57BL / 6N, Department of Animal Science, Peking University Health Science Center, 4 mice in each group). Samples were collected on the 14th day after surgery, fixed with 4% paraformaldehyde for 24 hours, and then scanned by Micro-CT. The three-dimensional reconstruction was analyzed. The specific method was as follows: a 0.6 cm long incision was made on the lateral side of the distal end of the femur of the mouse hind limb with a scalpel, the muscle and periosteum were separated, and the distal end of the femur was completely exposed; a ball drill was used to prepare a 1 mm diameter through defect at the distal end of the femur, and bone organoid repair materials were implanted. The muscles were sutured with absorbable sutures, and the skin was sutured with non-absorbable sutures. The wound was wiped with iodine to disinfect, and 10,000 penicillins were injected into the hind limb muscles for anti-infection. After 14 days, the mice were killed by cervical dislocation to collect samples; the femoral samples of mice were fixed with 4% paraformaldehyde for 2 days and then scanned with high-resolution Micro-CT. After scanning, the matching three-dimensional visualization software Inveon Research was used The tomographic images of the femoral defect site of mice were reconstructed three-dimensionally to further quantitatively analyze the bone mineral density (BMD), bone volume / total volume ratio (BV / TV), trabecular thickness (Tb.Th) and trabecular number (Tb.N).

[0083] The results are as follows Figure 4 As shown, we can see:

[0084] (1) The static cultured organoids of bone marrow mesenchymal stem cells (BMSCs) + bone marrow-derived macrophages (BMDMs) (Comparative Example 6) have better bone repair effects than the static cultured bone organoids of BMSCs (Comparative Example 8); the dynamic tensile stress bone organoids of BMSCs + BMDMs (Example 1) have better bone repair effects than the dynamic tensile stress bone organoids of BMSCs (Comparative Example 1), indicating that the addition of macrophages can better repair bone defects.

[0085] (2) BMSCs dynamic tensile stress bone organoids (Comparison Example 1) have better bone repair effect than BMSCs static culture bone organoids (Comparison Example 8); BMSCs+BMDMs dynamic tensile stress bone organoids (Example 1) have better bone repair effect than BMSCs+BMDMs static culture bone organoids (Comparison Example 6), indicating that bone organoids constructed based on dynamic tensile stress can better repair bone defects than statically cultured bone organoids.

[0086] (3) The repair effect of BMSCs+BMDMs dynamic tensile stress bone organoids (Example 1) was the best. After 14 days of implantation, the bone defect was almost filled with new trabeculae, which could achieve a repair effect comparable to that of autologous bone.

[0087] It can be seen from the above examples that:

[0088] (1) When constructing bone organoids, the present invention regulates cell fate through stress and regulates the bone immune microenvironment by introducing macrophages, thereby significantly accelerating the formation speed and quality of functional bone organoids.

[0089] (2) The bone organoids constructed by the present invention have good bone defect repair effects. 14 days after implantation, they have a repair effect comparable to that of the gold standard for treatment - autologous bone transplantation.

[0090] (3) The bone organoids constructed by the present invention can also be used as a model for studying bone tissue development and a drug screening model.

[0091] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these changes and variations. The above embodiments or implementations are merely illustrative of the present invention, and the present invention may also be implemented in other specific ways or other specific forms without departing from the gist or essential features of the present invention. Therefore, the described implementations should be considered illustrative rather than restrictive in any respect. The scope of the present invention should be described by the appended claims, and any changes equivalent to the intent and scope of the claims should also be included within the scope of the present invention.

Claims

1. A bone organoid, Features: The bone organoids are obtained by three-dimensionally culturing a cell mixture, wherein the cell mixture comprises stem cells and macrophages.

2. The bone organoid according to claim 1, Features: The stem cells are selected from one or more of umbilical cord blood mesenchymal stem cells, bone marrow mesenchymal stem cells, adipose mesenchymal stem cells, and induced pluripotent stem cells; The macrophages are bone marrow-derived macrophages and / or peripheral blood-derived macrophages.

3. The bone organoid according to claim 1 or 2, Features: The number ratio of the stem cells to the macrophages is (2-3):

1.

4. The bone organoid according to claim 1 or 2, Features: The cell mixture also contains a hydrogel matrix material.

5. The bone organoid according to claim 4, Features: The hydrogel matrix material is selected from one or more of methacrylated gelatin, hyaluronic acid, sodium alginate, silk fibroin, carboxymethyl chitosan, chondroitin sulfate, and collagen; The density of all cells formed in the hydrogel matrix material is (1-5)×10 6 Pieces / mL.

6. A method for constructing a bone organoid according to claim 4 or 5, It is characterized in that The construction method comprises the following steps: (1) uniformly mixing the materials in the cell mixture in a three-dimensional culture reactor; (2) solidifying the hydrogel matrix material; (3) Performing cell culture to obtain the bone organoid.

7. The construction method according to claim 6, Features: In step (1), the three-dimensional culture reactor is a three-dimensional culture reactor based on dynamic tensile stress.

8. The construction method according to claim 7, Features: The three-dimensional culture reactor based on dynamic tensile stress is subjected to plasma spraying treatment to remove impurities on the inner surface and poly-lysine coating on the inner surface to improve the hydrophilicity and adhesion of the inner surface before adding the cell mixture.

9. The construction method according to claim 7, Features: In step (2), the curing is photocuring, the wavelength of the photocuring is 400-420nm, and the photocuring time is 30-60s; In step (3), when cell culture is performed, the frequency of dynamic tensile stress is 0.5-0.8 Hz, the time is 2-3 h / day, and the ratio is 8-10%.

10. Use of the bone organoid according to any one of claims 1 to 5 for preparing bone repair materials or in vitro research models.

Citation Information

Patent Citations

  • Engineered M2 macrophage, whole-cell lysis buffer, hydrogel and application of engineered M2 macrophage

    CN118345119A

  • 3D in vitro bi-phasic cartilage-bone construct

    US20150093428A1

Cited By

  • Immunoactive fat organ and culture method and application thereof

    CN121555413A

  • Hydrogel microspheres and kit for constructing bone organs and application of hydrogel microspheres and kit

    CN121699852A

  • Bone-loaded organ hydrogel as well as preparation method and application thereof

    CN121718490A

  • Bone organ as well as construction method and application thereof

    CN121718491A